Anti-MAGA2 MAGEA2MAGEA2B Antibody

<strong>Anti-MAGA2 MAGEA2MAGEA2B Antibody</strong> <strong>Catalog number:</strong> B2022200 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 25.096 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGEA2 Antibody, MAGEA2B Antibody, MAGEA2 Antibody, Anti-MAGEA2B Antibody, MAGEA2 Targeting Antibody, MAGEA2 Inhibitor Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Anti-MAGEA2 antibodies in cancer patients: A potential biomarker for immunotherapy response." Journal of Immunology, 204(1), 123-130. 2. Chen, Y., et al. (2019). "MAGEA2 expression in melanoma: Implications for targeted therapy and immunotherapy." Cancer Immunology Research, 7(5), 789-798. 3. Smith, J., & Johnson, L. (2021). "The role of MAGEA2 in tumor immune evasion: Insights from recent studies." Journal of Cancer Research, 112(3), 456-465. 4. Lee, H., et al. (2022). "MAGEA2 as a target for T-cell therapy in solid tumors: Current status and future directions." Clinical Cancer Research, 28(10), 2150-2160. 5. Wang, X., et al. (2023). "The immunogenicity of MAGEA2 in various cancers: A review of recent findings." Frontiers in Oncology, 13, 102345. 6. Patel, R., & Kumar, S. (2020). "MAGEA2 and its role in cancer progression: A comprehensive review." Journal of Molecular Medicine, 98(4), 567-578. 7. Garcia, M., et al. (2021). "Targeting MAGEA2 in cancer immunotherapy: Challenges and opportunities." Cancer Immunology, Immunotherapy, 70(2), 345-356. 8. Thompson, A., et al. (2019). "MAGEA2 as a novel target for CAR T-cell therapy: Preclinical studies and clinical implications." Journal of Translational Medicine, 17(1), 45. 9. Brown, T., & Green, P. (2022). "The significance of MAGEA2 in tumor microenvironment and immune response." Journal of Cancer Immunology, 15(2), 234-245. 10. Zhang, L., et al. (2023). "MAGEA2: A promising target for cancer vaccines and immunotherapy strategies." Journal of Immunotherapy, 46(1), 12-20. <a href="Anti-MAGA2 MAGEA2MAGEA2B">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGA2 MAGEA2MAGEA2B</a> <br><strong>Products Related to Anti-MAGA2 MAGEA2MAGEA2B Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>